AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS for AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Labor-Health and Human Services Appropriations seeking additional Food and Drug Administration (FDA) funding. Communication to FDA on Rescheduling Hydrocodone containing mediations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH M HILL | — |
| BRIAN M MEYER | — |
| KAREN NOONAN | — |
| CHRISTOPHER J TOPOLESKI | — |
Medicare/Medicaid MMM
Communication with Centers for Medicare and Medicaid Services regarding Innovation Center and direct reimbursement under Medicare program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH M HILL | — |
| BRIAN M MEYER | — |
| KAREN NOONAN | — |
| CHRISTOPHER J TOPOLESKI | — |
Pharmacy PHA
H.R. 6413, support for the "Transitional Care Act of 2012." Contact concerning Food and Drug Administration (FDA) authority to manage drug shortages. Communication to FDA on approval of biosimilars and drug safety. Communications to Health Resources and Services Administration on 340B drug discount program. Communication with FDA and Centers for Disease Control and Prevention on compounding.Provided input on H.R. 6584, "Verifying Authority and Legality In Drug Compounding Act of 2012."
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH M HILL | — |
| BRIAN M MEYER | — |
| KAREN NOONAN | — |
| CHRISTOPHER J TOPOLESKI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.